Wolverine Trading
APLT

Wolverine Trading’s Applied Therapeutics APLT Stock Holding History

Wolverine Trading’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,400
Closed -$10.1K – 4703
2024
Q4 		$10.1K Buy
+12,400
New +$77.7K ﹤0.01% 5155

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Wolverine Trading's APLT Position: Q3 2025 in Review

Wolverine Trading opened a new position in Applied Therapeutics (APLT) in Q3 2025: 20,405 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #5553 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in APLT as recently as Q4 2024.

Wolverine Trading first reported a position in APLT in Q4 2023 and has held it in 4 quarters since. The position peaked at $53K in Q2 2024. 70 funds tracked by Wall St. Rank hold APLT as of Q3 2025.

  • Wolverine Trading held 20,405 shares of Applied Therapeutics worth $12.5K as of Q3 2025.
  • Applied Therapeutics was a new Wolverine Trading position in Q3 2025.
  • Applied Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5553 holding.
  • Wolverine Trading first reported a position in Applied Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • Wolverine Trading's Applied Therapeutics position peaked at $53K in Q2 2024.
  • 70 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.